| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |